With more than 50 years’ experience in diversified international business, Eli is a well-established and prolific journalist, having authored nearly 2,000 articles on job market, workplace ...

The unscripted market might be beginning to settle after a chaotic few years, but the over-reliance on recommissions needs to end, says Sony Pictures Television Nonfiction boss Eli Holzman.

One of Eli Lilly's potential competitors in the weight loss market just reported unimpressive trial results. The company could benefit from the government coverage of its weight loss medicines.

For IndieWire, Roth explains why Damien Leone's killer clown franchise reminds him of his own "Hostel." “There’s no hard and fast rule to anything,” Roth said, speaking to IndieWire for the ...

Evercore ISI analyst Umer Raffat maintained a Hold rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last Friday at $746.20. Don't Miss our Black Friday ...

In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price target of $994.00. The company’s shares closed last ...

Stephenson will return to the lineup on the road Tuesday against the Hurricanes, according to Julian Gaudio of The Hockey News. Stephenson missed his first game of the season Saturday due to an ...

Chandler Stephenson (Kraken) with a Goal vs. Sharks, 11/29/2024 ...

Stephenson posted two helpers in 19:52 of ice time Sunday in a 7-5 win over the Rangers. Stephenson registered the primary assist on Oliver Bjorkstrand's power-play marker in the second period ...

On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks. They discuss the challenges of developing products that counter diseases and ...